Supported by an educational donation provided by Amgen, Inc.
Despite educational efforts for the past 20 years, a huge gap still exists in starting the fragility fracture patient on medications for osteoporosis after fracture. Fear that the medications will interfere with the fracture healing process and potentially cause addtional problems for the patient are just a few of the many impediments to the care of these patients.
This webinar will review the evidence based information that is available looking at the effects of osteoporosis medications on fracture healing and the potential pros and cons of treatment in the acute setting. It will also look at Atypical Femur Fracture patients and discuss how we might need to treat them both surgically and medically until they heal. The goal of this webinar is to provide the practitioner with a clear understanding of the known effects of these medications on fracture repair and provide guidance about the appropriate choice of medications and timing of medications in the fragility fracture patient’s care.
As a result of the webinar participants will be able to:
- Discuss the currently available medications used for osteoporosis and the effects that these medications may have on fracture healing.
- Identify the timing of osteoporosis medication treatments for patients with an acute fracture, particularly hip fractures.
- Review both the current surgical and medical clinical care paradigms for patients presenting with Atypical Femur fractures.
Length: 60 minutes